Does Ultrasound Guidance Improve the Effectiveness of Neurotoxin Injections in Patients with Cervical Dystonia? (A Prospective, Partially-Blinded, Clinical Study)

Aim: The aim of this study was to evaluate the efficacy of ultrasound guidance (US) in the treatment of cervical dystonia (CD) with botulinum neurotoxin type A (BoNT-A) injections in comparison to anatomical landmarks (AL). To date, US is routinely used in many centers, but others deny its usefulness. Materials and Methods: Thirty-five patients (12 males, 23 females) with a clinical diagnosis of CD were included in the study. Intramuscular administration of BoNT-A was performed using either US guidance, or with AL, in two separate therapeutic sessions. The efficacy of BoNT-A administration was assessed with the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS), Tsui modified scale, Craniocervical Dystonia Questionnaire (CDQ-24) and Clinical Global Impression—Improvement scale (CGI-I). Additionally, patients at therapeutic sessions were digitally recorded and evaluated by two blinded and independent raters. Results: A significant decrease in total TWSTRS, severity subscale TWSTRS, Tsui score, and CDQ-24 was found in both the AL and US group; however, in the TWSTRS disability and pain subscales, a significant decrease was found only in the US group. Moreover, US guided treatment also resulted in a greater decrease in TWSTRS, Tsui score and CDQ-24 compared to anatomical landmarks use only. Conclusions: US guidance might be helpful in improving the results of BoNT-A injections in cervical dystonia, reducing associated pain and disability; however, more studies are needed to evaluate its clinical efficacy.

[1]  L. Defebvre,et al.  Does ultrasound-guidance improve the outcome of botulinum toxin injections in cervical dystonia? , 2021, Revue Neurologique.

[2]  W. Jost,et al.  Botulinum neurotoxin in cervical dystonia revisited - recent advances and unanswered questions. , 2021, Neurologia i neurochirurgia polska.

[3]  D. Dressler,et al.  Dysphagia in cervical dystonia patients receiving optimised botulinum toxin therapy: a single-center retrospective cohort study , 2020, Journal of Neural Transmission.

[4]  L. Defebvre,et al.  Anatomy‐guided injections of botulinum neurotoxin in neck muscles: how accurate is needle placement? , 2020, European journal of neurology.

[5]  W. Jost,et al.  Cervical dystonia - improving the effectiveness of botulinum toxin therapy. , 2020, Neurologia i neurochirurgia polska.

[6]  W. Jost,et al.  Preferred muscles in cervical dystonia. , 2020, Neurologia i Neurochirurgia Polska.

[7]  W. Jost,et al.  Injection into the Longus Colli Muscle via the Thyroid Gland , 2019, Tremor and other hyperkinetic movements.

[8]  I. Odderson,et al.  Ultrasound and Electromyography Guidance for Injection of the Longus Colli With Botulinum Toxin for the Treatment of Cervical Dystonia. , 2016, Ultrasound quarterly.

[9]  S. Factor,et al.  Botulinum toxin treatment failures in cervical dystonia: causes, management, and outcomes , 2016, Journal of Neurology.

[10]  W. Jost,et al.  Selection of Muscles for Botulinum Toxin Injections in Cervical Dystonia , 2015, Movement disorders clinical practice.

[11]  C. Colosimo,et al.  Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia. , 2015, Parkinsonism & related disorders.

[12]  W. Jost,et al.  Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement , 2014, Journal of Neural Transmission.

[13]  M. Munin,et al.  Elimination of dysphagia using ultrasound guidance for botulinum toxin injections in cervical dystonia , 2012, Muscle & nerve.

[14]  M. Yokoe,et al.  Sonographic guidance provides a low‐risk approach to the longus colli muscle , 2012, Movement disorders : official journal of the Movement Disorder Society.

[15]  J. Jankovic,et al.  Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE) , 2011, BMC neurology.

[16]  R. Bhidayasiri Treatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responses. , 2011, Parkinsonism & related disorders.

[17]  A. Albanese,et al.  EFNS guidelines on diagnosis and treatment of primary dystonias , 2011, European journal of neurology.

[18]  Y. Yoon,et al.  Initial experience with imaging-guided intramuscular botulinum toxin injection in patients with idiopathic cervical dystonia. , 2009, AJR. American journal of roentgenology.

[19]  D M Simpson,et al.  Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) , 2008, Neurology.

[20]  R. Barbano,et al.  Treatment recommendations and practical applications of botulinum toxin treatment of cervical dystonia. , 2008, Neurologic clinics.

[21]  Su Jin Lee,et al.  Localization of Dystonic Muscles with 18F-FDG PET/CT in Idiopathic Cervical Dystonia , 2007, Journal of Nuclear Medicine.

[22]  C. Comella,et al.  Treatment of cervical dystonia with botulinum toxins , 2006, Journal of neural transmission.

[23]  J. D. Speelman,et al.  Cervical dystonia and botulinum treatment: Is electromyographic guidance necessary? , 1995, Movement disorders : official journal of the Movement Disorder Society.

[24]  G. Reichel,et al.  Zur Phänomenologie der zervikalen Dystonien Vorschlag einer neuen Behandlungsstrategie mit Botulinumtoxin The Phenomenology of Cervical Dystonia Proposed New Treatment Strategy with Botulinum Toxin , 2009 .

[25]  R. Benecke,et al.  Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group. , 1999, Journal of neurology.